What should I do if Jisandai (Bingtonsha) relapses after taking it for three months?

Epclusa (Epclusa) is a drug used to treat chronic hepatitis B, containing sofosbuvir (Sofosbuvir) and velpatasvir (Velpatasvir). It is widely used in the treatment of chronic hepatitis B and is effective in many patients. However, some patients may relapse after treatment with GISANDA (Bingtonsa), which requires special attention and treatment.

If hepatitis B relapses after three months of taking Jisandai (Bingtonsha) it is recommended that the patient first undergo a comprehensive examination. Doctors will recommend a viral load test to check whether the virus is still present and to assess how the virus is mutating. Relapses may be caused by viral mutations, increased drug tolerance, or other factors. Understanding the specifics of the virus is critical to developing subsequent treatment plans.

Causes of relapse may be related to treatment compliance. Patients need to make sure they take their medications on time and avoid missing doses or not taking them the way their doctor recommends. Any failure to follow your doctor's instructions may result in less effective treatment, increasing the risk of recurrence. If patients have ever missed taking medication, they should discuss it with their doctor and try to avoid similar problems in future treatments.

If it is determined that the relapse is not due to treatment compliance issues, your doctor may consider adjusting your treatment plan. This may include switching to other antiviral medications, or using other medications in combination to enhance the effectiveness of treatment. Depending on the patient's specific circumstances, the doctor may recommend a different treatment regimen, such as choosing a different drug combination or increasing the number of treatment cycles.

In addition, regular follow-up and monitoring are very important for patients who relapse. Doctors will regularly check the patient's liver function and viral load to evaluate the treatment effect and adjust the treatment plan in a timely manner. This helps ensure patients receive the most effective treatment and minimize the risk of recurrence.